JPMorgan Chase & Co’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$453K Buy
49,138
+566
+1% +$5.22K ﹤0.01% 4114
2025
Q1
$417K Buy
48,572
+7,749
+19% +$66.5K ﹤0.01% 4114
2024
Q4
$438K Sell
40,823
-1,742
-4% -$18.7K ﹤0.01% 4214
2024
Q3
$242K Buy
42,565
+1,191
+3% +$6.77K ﹤0.01% 4390
2024
Q2
$175K Sell
41,374
-6,535
-14% -$27.6K ﹤0.01% 4340
2024
Q1
$244K Sell
47,909
-16,527
-26% -$84.1K ﹤0.01% 4357
2023
Q4
$600K Buy
64,436
+352
+0.5% +$3.28K ﹤0.01% 3810
2023
Q3
$420K Buy
64,084
+4,798
+8% +$31.4K ﹤0.01% 3814
2023
Q2
$482K Buy
59,286
+1,564
+3% +$12.7K ﹤0.01% 3787
2023
Q1
$495K Buy
57,722
+13,748
+31% +$118K ﹤0.01% 3837
2022
Q4
$407K Buy
43,974
+253
+0.6% +$2.34K ﹤0.01% 3862
2022
Q3
$452K Buy
43,721
+3,026
+7% +$31.3K ﹤0.01% 3804
2022
Q2
$408K Sell
40,695
-785
-2% -$7.87K ﹤0.01% 3989
2022
Q1
$511K Buy
41,480
+8,141
+24% +$100K ﹤0.01% 3977
2021
Q4
$578K Buy
33,339
+8,741
+36% +$152K ﹤0.01% 3977
2021
Q3
$440K Sell
24,598
-8,765
-26% -$157K ﹤0.01% 4032
2021
Q2
$763K Buy
33,363
+11,033
+49% +$252K ﹤0.01% 3782
2021
Q1
$334K Sell
22,330
-40,424
-64% -$605K ﹤0.01% 4240
2020
Q4
$339K Buy
62,754
+43,055
+219% +$233K ﹤0.01% 3948
2020
Q3
$93K Sell
19,699
-22,185
-53% -$105K ﹤0.01% 4076
2020
Q2
$206K Buy
41,884
+28,139
+205% +$138K ﹤0.01% 3654
2020
Q1
$43K Sell
13,745
-329
-2% -$1.03K ﹤0.01% 4182
2019
Q4
$36K Hold
14,074
﹤0.01% 4320
2019
Q3
$44K Buy
14,074
+2,283
+19% +$7.14K ﹤0.01% 4301
2019
Q2
$38K Buy
+11,791
New +$38K ﹤0.01% 4358
2018
Q2
Sell
-7,939
Closed -$22K 4760
2018
Q1
$22K Sell
7,939
-111
-1% -$308 ﹤0.01% 4390
2017
Q4
$26K Buy
+8,050
New +$26K ﹤0.01% 4331
2017
Q2
Sell
-18,261
Closed -$105K 4325
2017
Q1
$105K Buy
+18,261
New +$105K ﹤0.01% 3716